The planned trials of experimental Ebola drugs in West Africa do not have the full support of medical experts because there is not enough proof that these drugs work, the World Health
Organization (WHO) said Friday, dpa reported.
There are only a small number of really promising drugs, WHO official Martin Friede said, dampening hopes for a quick cure for Ebola.
The medical aid group Medecins Sans Frontieres (MSF) announced Thursday that it planned tests starting in December of the Japanese influenza drug Favipiravir in Guinea and the US experimental antiviral drug Brincidofovir at a location to be determined.
MSF chose these two drugs because they would be quickly available in large amounts if the trial results are positive.
GMT 13:50 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 13:20 2018 Monday ,29 October
National campaign to raise awareness of breast cancerGMT 14:34 2018 Friday ,19 October
Birth spacing "improving health of Omani women"GMT 15:35 2018 Thursday ,11 October
Russia to discuss issue of biological labs near its bordersGMT 16:14 2018 Saturday ,29 September
Premier Khalifa bin Salman congratulated by health ministerGMT 16:10 2018 Saturday ,29 September
Bahrain to host Dermatology, Laser and Aesthetics ConferenceGMT 12:44 2018 Friday ,28 September
EU proposes €40 million for UNRWA to keep health clinics openGMT 07:46 2018 Wednesday ,26 September
HRH Premier to address UN high-level health meetingsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor